Methamphetamine-specific IVD, kit, rapid ICT, clinical

Methamphetamine-specific IVDs in this category are rapid diagnostic tests designed to detect the presence of methamphetamine in clinical specimens, such as urine or blood, within minutes. These kits use immunochromatographic technology (lateral flow tests) to provide quick results for clinical or point-of-care settings, helping healthcare providers assess substance use or confirm exposure in emergency or outpatient scenarios.

These tests are typically regulated as in vitro diagnostics (IVDs) and may require compliance with standards for rapid testing, accuracy, and performance validation. They are supplied as kits containing all necessary reagents and instructions for use, often intended for laboratory or professional point-of-care use—never for self-testing. Regulations may vary by jurisdiction, but they generally require validation for clinical reliability and adherence to safety and labeling requirements.